These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 36637960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ, Ying G.
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [Abstract] [Full Text] [Related]

  • 4. The Usefulness of Anti-acetylcholine Receptor Binding Antibody Testing in Diagnosing Ocular Myasthenia Gravis.
    Chung IY, Sheth SJ, Wells KK, Campbell TG.
    J Neuroophthalmol; 2021 Dec 01; 41(4):e627-e630. PubMed ID: 32868574
    [Abstract] [Full Text] [Related]

  • 5. Low probability of myasthenia Gravis in patients presenting to neuro-ophthalmology clinic for evaluation of isolated ptosis.
    Donaldson L, Issa M, Dezard V, Margolin E.
    Eur J Ophthalmol; 2023 Jan 01; 33(1):524-529. PubMed ID: 35686323
    [Abstract] [Full Text] [Related]

  • 6. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK, Barohn RJ, Pasnoor M, McVey A, Herbelin L, Whittaker T, Dimachkie M.
    J Clin Neuromuscul Dis; 2011 Sep 01; 13(1):46-52. PubMed ID: 22361625
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Valko Y, Wirth MA, Fierz FC, Schesny MK, Rosengren S, Schmückle-Meier T, Bockisch CJ, Straumann D, Schreiner B, Weber KP.
    Neurology; 2024 May 01; 102(10):e209395. PubMed ID: 38669629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature.
    de Meel RHP, Raadsheer WF, van Zwet EW, Tannemaat MR, Verschuuren JJGM.
    J Neuromuscul Dis; 2019 May 01; 6(3):369-376. PubMed ID: 31424417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ice pack test: is it obsolete?
    Rajasekharan C, Anishkumar V, Suresh MK.
    BMJ Case Rep; 2011 Jul 28; 2011():. PubMed ID: 22689834
    [Abstract] [Full Text] [Related]

  • 15. Inferior oblique muscle paresis as a sign of myasthenia gravis.
    Almog Y, Ben-David M, Nemet AY.
    J Clin Neurosci; 2016 Mar 28; 25():50-3. PubMed ID: 26531848
    [Abstract] [Full Text] [Related]

  • 16. Clinical Characteristics Associated With Secondary Generalization in Patients With Ocular Myasthenia Gravis: A Systematic Review and Meta-analysis.
    Fang CEH, Bokre D, Wong SH.
    Neurology; 2023 Oct 17; 101(16):e1594-e1605. PubMed ID: 37643888
    [Abstract] [Full Text] [Related]

  • 17. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT.
    JAMA Neurol; 2015 Oct 17; 72(10):1170-4. PubMed ID: 26258604
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of Tensilon-Negative Ocular Myasthenia Gravis By Daily Selfie.
    Guterman EL, Botelho JV, Horton JC.
    J Neuroophthalmol; 2016 Sep 17; 36(3):292-3. PubMed ID: 27529328
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.